Sickle Cell Disease Management and Treatment Initiatives

This case study explores Novartis' commitment to combating sickle cell disease (SCD) through innovative programs in Africa. It highlights the challenges faced, including access to treatment and newborn screening, and showcases multisector partnerships aimed at improving health equity. The document details initiatives like the Novartis Africa Sickle Cell Disease program, collaborations with organizations, and advancements in gene therapy to enhance patient outcomes and reduce mortality rates.